[Case of occupational lung cancer cured by early diagnosis and surgical procedure].
Explore the source record for details and available documents.
Adenocarcinoma↗
Biomedical subjects
K Matsuba
Publications and source records attributed to K Matsuba.
[Therapeutic results of Perthes' disease].
Explore the source record for details and available documents.
Adolescent↗
Long-term effects of bezafibrate on in vivo VLDL-triglyceride production in the rat.
Long-term effects of bezafibrate on in vivo production of VLDL-triglyceride were studied in the rat. Bezafibrate given at a daily dose of 30 mg/kg body weight for 14 days produced a decrease not only in triglyceride by 51% but in cholesterol by 28% and phospholipid by 18%. Despite a marked reduction in plasma triglyceride concentrations, there was no significant change in the rate of VLDL-triglyceride secretion from the liver into the circulation between bezafibrate-treated and control animals (1113 +/- 58 and 1234 +/- 63 micrograms/min, respectively). In addition, bezafibrate produced no change in lipid composition in VLDL. These results suggest that bezafibrate enhances triglyceride removal from the circulation, which leads to reduction in plasma triglyceride.
Animals↗
Recommendation for strict control of plasma triglyceride in diabetic subjects.
Explore the source record for details and available documents.
Cholesterol↗